ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 910,64
0,99%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Bradley Pharmaceuticals (BDY)

  7. Bradley Pharmaceuticals (BDY) Actualités

BDY

Bradley (BDY)

Bradley Pharmaceuticals
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:BDY
DateHeureSourceTitreSymboleSociété
13/05/200814h18PR Newswire (US)Medimetriks Pharmaceuticals, Inc. Begins OperationsNYSE:BDYBradley Pharmaceuticals
22/02/200800h54PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care IndexNYSE:BDYBradley Pharmaceuticals
22/02/200800h00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Current report filing (8-K)NYSE:BDYBradley Pharmaceuticals
22/02/200800h00Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)NYSE:BDYBradley Pharmaceuticals
21/02/200823h55Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NYSE:BDYBradley Pharmaceuticals
21/02/200823h02Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Termination of Registration of a Class of Security under Section 12(g) (15-12G/A)NYSE:BDYBradley Pharmaceuticals
14/02/200823h51PR Newswire (US)Standard & Poor's Announces Change to U.S. IndexNYSE:BDYBradley Pharmaceuticals
14/02/200817h36Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NYSE:BDYBradley Pharmaceuticals
23/01/200823h20Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended tender offer statement by Issuer (SC TO-I/A)NYSE:BDYBradley Pharmaceuticals
17/01/200823h14Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:BDYBradley Pharmaceuticals
17/01/200823h07PR Newswire (US)Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger WitNYSE:BDYBradley Pharmaceuticals
17/01/200818h19Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)NYSE:BDYBradley Pharmaceuticals
17/01/200818h12Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NYSE:BDYBradley Pharmaceuticals
14/12/200713h45PR Newswire (US)Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%NYSE:BDYBradley Pharmaceuticals
11/12/200712h01Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)NYSE:BDYBradley Pharmaceuticals
26/11/200723h06Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NYSE:BDYBradley Pharmaceuticals
26/11/200713h45PR Newswire (US)Bradley Pharmaceuticals Launches ROSULA(R) CLK(TM)NYSE:BDYBradley Pharmaceuticals
08/11/200722h51PR Newswire (US)Bradley Pharmaceuticals 2007 Third Quarter ResultsNYSE:BDYBradley Pharmaceuticals
08/11/200722h47Edgar (US Regulatory)Bradley Pharmaceuticals Inc - Quarterly Report (10-Q)NYSE:BDYBradley Pharmaceuticals
30/10/200714h17PR Newswire (US)Nycomed Signs Definitive Agreement to Acquire Bradley Pharmaceuticals, Inc., Strengthening US Specialty BusinessNYSE:BDYBradley Pharmaceuticals
30/10/200713h00PR Newswire (US)Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in CashNYSE:BDYBradley Pharmaceuticals
28/09/200713h45PR Newswire (US)Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual MeetingNYSE:BDYBradley Pharmaceuticals
10/08/200706h36PR Newswire (US)Bradley Pharmaceuticals Special Committee Receives Non-binding Preliminary BidsNYSE:BDYBradley Pharmaceuticals
10/08/200700h10PR Newswire (US)Bradley Pharmaceuticals 2007 Second Quarter ResultsNYSE:BDYBradley Pharmaceuticals
31/07/200713h45PR Newswire (US)Bradley Pharmaceuticals to Report Second Quarter 2007 Financial Results and Schedules Conference CallNYSE:BDYBradley Pharmaceuticals
28/06/200714h45PR Newswire (US)Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)NYSE:BDYBradley Pharmaceuticals
21/06/200714h00Business WireNew Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aNYSE:BDYBradley Pharmaceuticals
20/06/200717h30PR Newswire (US)New, Effective Low Dose Estrogen Therapy Introduced to National MediaNYSE:BDYBradley Pharmaceuticals
15/06/200714h45PR Newswire (US)Bradley Pharmaceuticals Launches Peranex(TM) HC CreamNYSE:BDYBradley Pharmaceuticals
13/06/200714h45PR Newswire (US)Bradley Pharmaceuticals Announces Launch of Elestrin(TM)NYSE:BDYBradley Pharmaceuticals
 Showing the most relevant articles for your search:NYSE:BDY

Dernières Valeurs Consultées

USOTC
MNBEY
Minebea Mitsumi (PK)
ZBCM
BICOUSDT
Biconomy Token
USOTC
ASPU
Aspen (QB)
USOTC
CSMYF
Cosmos Pharmaceutical (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés